Literature DB >> 18600297

Response to genetic manipulations of liver angiotensinogen in the physiological range.

Barbu Gociman1, Andreas Rohrwasser1, Elaine Hillas1, Tong Cheng1, Grant Hunter1, Jennifer Hunter1, Paul Lott1, Smith Monson1, Jian Ying1, J M Lalouel2.   

Abstract

Genetic variation in the human angiotensinogen gene (AGT) influences plasma AGT concentration and susceptibility to essential hypertension by a mechanism that remains to be clarified. When one or two additional copies of the gene were inserted by gene titration (by homologous recombination with gap-repair at the AGT locus), both plasma AGT and arterial pressure were elevated in the physiological range in the mouse. The causal dependency between plasma AGT and blood pressure and the relative contribution of the various tissues that express AGT to these two phenotypic parameters remained to be determined. To address these issues, we generated a transgenic mouse with overexpression of the mouse AGT gene restricted to the liver. The transgene was examined in two contrasted genetic backgrounds, the sodium-sensitive C57BL/6J and the sodium-resistant A/J. Transgenic and control male animals underwent continuous cardiovascular monitoring by telemetry for 14 days while under a standard sodium diet (0.2%). Moderate but significant increases in plasma AGT (40%, p = 0.01) and systolic blood pressure (4-6 mmHg, p ranging from 0.01 to <0.001) were observed in the sodium-sensitive background, but not in the sodium-resistant animals. Statistical analysis of a large number of consecutive, repeated measurements of blood pressure afforded power to detect small effects in the physiological range by use of advanced mixed models of analysis of variances and covariances. Although plasma renin activity was increased in the sodium-sensitive background, it did not reach statistical significance. These observations underline a potential contribution of systemic AGT to the mechanism of AGT-mediated hypertension, but the significance of sodium sensitivity in the genetic background suggests participation of the kidney in expression of the elevated blood pressure phenotype, a matter that will warrant further studies. They also highlight the challenge of identifying the contribution of individual genes in complex inheritance, as their effects are modulated by other genetic and environmental determinants.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18600297     DOI: 10.1007/s10038-008-0311-1

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  39 in total

1.  Genetic susceptibility to essential hypertension: insight from angiotensinogen.

Authors:  Jean-Marc Lalouel; Andreas Rohrwasser
Journal:  Hypertension       Date:  2007-01-22       Impact factor: 10.190

2.  Lower blood pressure in floxed angiotensinogen mice after adenoviral delivery of Cre-recombinase.

Authors:  David E Stec; Henry L Keen; Curt D Sigmund
Journal:  Hypertension       Date:  2002-02       Impact factor: 10.190

Review 3.  Genetic analysis of inherited hypertension in the rat.

Authors:  J P Rapp
Journal:  Physiol Rev       Date:  2000-01       Impact factor: 37.312

4.  Angiotensinogen T235 expression is elevated in decidual spiral arteries.

Authors:  T Morgan; C Craven; L Nelson; J M Lalouel; K Ward
Journal:  J Clin Invest       Date:  1997-09-15       Impact factor: 14.808

5.  Acute and chronic dose-response relationships for angiotensin, aldosterone, and arterial pressure at varying levels of sodium intake.

Authors:  A W Cowley; R E McCaa
Journal:  Circ Res       Date:  1976-12       Impact factor: 17.367

6.  Novel mechanism of hypertension revealed by cell-specific targeting of human angiotensinogen in transgenic mice.

Authors:  R L Davisson; Y Ding; D E Stec; J F Catterall; C D Sigmund
Journal:  Physiol Genomics       Date:  1999-07-15       Impact factor: 3.107

7.  Adipose angiotensinogen is involved in adipose tissue growth and blood pressure regulation.

Authors:  F Massiéra; M Bloch-Faure; D Ceiler; K Murakami; A Fukamizu; J M Gasc; A Quignard-Boulange; R Negrel; G Ailhaud; J Seydoux; P Meneton; M Teboul
Journal:  FASEB J       Date:  2001-10-15       Impact factor: 5.191

8.  An animal model for cystic fibrosis made by gene targeting.

Authors:  J N Snouwaert; K K Brigman; A M Latour; N N Malouf; R C Boucher; O Smithies; B H Koller
Journal:  Science       Date:  1992-08-21       Impact factor: 47.728

9.  An albumin enhancer located 10 kb upstream functions along with its promoter to direct efficient, liver-specific expression in transgenic mice.

Authors:  C A Pinkert; D M Ornitz; R L Brinster; R D Palmiter
Journal:  Genes Dev       Date:  1987-05       Impact factor: 11.361

10.  Comparative studies on species-specific reactivity between renin and angiotensinogen.

Authors:  T Hatae; E Takimoto; K Murakami; A Fukamizu
Journal:  Mol Cell Biochem       Date:  1994-02-09       Impact factor: 3.396

View more
  3 in total

1.  Overexpression of mouse angiotensinogen in renal proximal tubule causes salt-sensitive hypertension in mice.

Authors:  Jian Ying; Deborah Stuart; Elaine Hillas; Barbu R Gociman; Nirupama Ramkumar; Jean-Marc Lalouel; Donald E Kohan
Journal:  Am J Hypertens       Date:  2012-03-01       Impact factor: 2.689

2.  Nonmodulation as the mechanism for salt sensitivity of blood pressure in individuals with hypertension and type 2 diabetes mellitus.

Authors:  Patricia C Underwood; Bindu Chamarthi; Jonathan S Williams; Anand Vaidya; Rajesh Garg; Gail K Adler; Marissa P Grotzke; Gitana Staskus; Devendra Wadwekar; Paul N Hopkins; Claudio Ferri; Anthony McCall; Donald McClain; Gordon H Williams
Journal:  J Clin Endocrinol Metab       Date:  2012-08-03       Impact factor: 5.958

3.  A possible interaction between systemic and renal angiotensinogen in the control of blood pressure.

Authors:  Nirupama Ramkumar; Deborah Stuart; Jian Ying; Donald E Kohan
Journal:  Am J Hypertens       Date:  2013-01-31       Impact factor: 2.689

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.